UNSPSC 51281600: Aminoglycosides

This classification denotes glycosylated compounds and antibiotics in which there is an amino substituent on the glycoside, which are therefore called AMINOGLYCOSIDES.

UNSPSC 51281600 Aminoglycosides is a Class code, but the recent state and local opportunities tagged under it do not reflect aminoglycoside procurement — instead, they span naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, emergency medical supplies, and generic multi-source pharmaceuticals. The code shows little relevant recent activity aligned with its nominal scope. The most concrete solicitation matching any pharmaceutical commodity is the City of Tampa Fire Department Rescue Division's IFB for medical and first aid supplies (169 line items including respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, and consumables), but that procurement spans broad emergency response inventory rather than aminoglycosides specifically. Issuing bodies across these opportunities include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal purchasing departments (City of Tampa), and multistate cooperative purchasing vehicles (Minnesota MMCAP), reflecting the fragmented jurisdictional landscape of state and local pharmaceutical procurement.

Activity spans Florida, Texas, Minnesota, and Oregon through MMCAP's multistate vehicle. The Tampa Fire Department's medical and first aid supplies IFB (26P00145, due March 13, 2026, $700,000 estimated award, sheltered for certified Small Local Business Enterprises with a 5% bid discount) represents the most directly relevant recent opportunity. The Minnesota MMCAP RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) solicits manufacturers through three authorized wholesalers with awards effective July 1, 2026, though this covers broad generic and OTC categories rather than aminoglycosides. The Texas HHS Commission's RFI on direct-to-manufacturer prescriptions (HHS0017013, April 3, 2026) is exploratory and does not specify pharmaceutical categories. Seminole County's naloxone and drug deactivation systems bid (IFB60459723LAS, 1,900 units naloxone and 800 deactivation systems annually) falls outside the code's scope entirely. Businesses evaluating this code should treat it as showing minimal targeted demand for aminoglycosides at the state and local level based on recent solicitation activity.